Friday, August 24, 2012

Google Alert - pharmaceutical news

News9 new results for pharmaceutical news
 
Pharmaceuticals: June quarter shows the way
Business Standard
Stock picking isn't easy, especially when profitability of the country's top 30 companies plummeted to single-digit levels. Strategists say there is a "drought of ideas", as few sectors are likely to report strong sales and profit numbers through 2012 ...
See all stories on this topic »
4 Pharmaceutical Stocks to Sell Now
Investorplace.com
The overall ratings of four Pharmaceutical stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). Warner Chilcott (NASDAQ:WCRX) is on the decline this week, earning a D ("sell") after receiving ...
See all stories on this topic »
Synergy Pharmaceuticals Acquires FV-100 Shingles Drug From Bristol-Myers ...
Stockhouse
23, 2012 (GLOBE NEWSWIRE) -- Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a developer of new drugs to treat gastrointestinal disorders and diseases, today announced that it has signed an Asset Purchase Agreement with Bristol-Myers Squibb Company ...
See all stories on this topic »
Pharmaceutical Manufacturer to Create 200 Jobs in Nash County
Equities.com
Hospira is the world's largest generic injectable pharmaceutical manufacturer. The company's products are used by hospitals, outpatient clinics and other healthcare sites, such as clinics and home-health facilities. The company currently has about 2 ...
See all stories on this topic »
The Morning Briefing: Pharmaceutical patents
SmartPlanet.com (blog)
"The Morning Briefing" is SmartPlanet's daily roundup of must-reads from the web. This morning we're reading about pharmaceutical patents. 1.) Drug patent issue too sensitive for trade negotiations. Europe's demand that Canada expand the patent rights ...
See all stories on this topic »
Par Pharmaceutical Companies Incorporated Stock Rating Reaffirmed by ...
Daily Political
Par Pharmaceutical Companies Incorporated (NYSE: PRX)'s stock had its "hold" rating restated by analysts at Needham & Company in a research report issued to clients and investors on Friday. A number of other firms have also recently commented on PRX.
See all stories on this topic »
West Pharma begins construction of new compression molding facility at Sri ...
pharmabiz.com
West Pharmaceutical India Packaging Private Limited, a subsidiary of West Pharmaceutical Services Inc, Lionville USA, has started construction of its new compression molding manufacturing facility at Sri City in Chittoor district of Andhra Pradesh ...
See all stories on this topic »
Pharma industry seen at $60bn by end of 12th plan
Moneycontrol.com
The overall pharmaceutical industry was pegged at Rs 1,000 billion (~USD 20 billion) with the domestic pharma industry at over Rs 600 billion (~USD 12 billion) in 2009-10. The bulk drugs contributed to about Rs 420 billion (USD 8.4 billion). The ...
See all stories on this topic »
Morgan Stanley Raises Watson Pharmaceuticals Incorporated EPS Estimates ...
Daily Political
Watson Pharmaceuticals Incorporated logo Investment analysts at Morgan Stanley lifted their earnings per share estimates on shares of Watson Pharmaceuticals Incorporated (NYSE: WPI) in a note issued to investors on Friday. The firm currently has an ...
See all stories on this topic »


Tip: Use quotes ("like this") around a set of words in your query to match them exactly. Learn more.

Delete this alert.
Create another alert.
Manage your alerts.

0 comments:

Post a Comment

Bullets

Total Pageviews

Pages

Twitter Delicious Facebook Digg Stumbleupon Favorites More

 
Design by Free WordPress Themes | Bloggerized by Lasantha - Premium Blogger Themes | Web Hosting Bluehost